MedPath

Resveratrol

Generic Name
Resveratrol
Drug Type
Small Molecule
Chemical Formula
C14H12O3
CAS Number
501-36-0
Unique Ingredient Identifier
Q369O8926L

Overview

Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet irradiation. In a 2004 issue of Science, Dr. Sinclair of Harvard University said resveratrol is not an easy molecule to protect from oxidation. It has been claimed that it is readily degraded by exposure to light, heat, and oxygen. However, studies find that Trans-resveratrol undergoes negligible oxidation in normal atmosphere at room temperature.

Indication

Being investigated for the treatment of Herpes labialis infections (cold sores).

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/11/14
Phase 2
Completed
Khyber Medical University Peshawar
2022/06/08
Not Applicable
UNKNOWN
2021/12/29
Not Applicable
Completed
2021/05/14
Phase 3
Completed
Sun Yat-sen University
2021/04/30
Phase 2
Completed
Khyber Medical University Peshawar
2021/03/16
Not Applicable
UNKNOWN
2020/12/30
N/A
Completed
2020/12/16
Phase 1
Completed
Jupiter Orphan Therapeutics Inc.
2020/06/26
Early Phase 1
Recruiting
2020/05/26
Phase 2
Terminated
Marvin McCreary, MD

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Hydra Longevity Cellular Energy
444673
Medicine
A
3/27/2024
LipoCap Resveratrol
484562
Medicine
A
3/28/2025
NRgize+
427853
Medicine
A
11/14/2023
FcMzit Women’s Multivitamin
490786
Medicine
A
6/4/2025
Beyond Alpha EstroControl
481466
TW Health Pty Ltd
Medicine
A
3/3/2025
Melrose FutureLab Time Capsule Daily Longevity Complex
491947
Medicine
A
6/17/2025
Soodox VITALITY NRC
485706
Medicine
A
4/10/2025
Pure Resveratrol
441995
Genetic Labs Australia
Medicine
A
2/22/2024
Meno Vital
471545
Medicine
A
12/3/2024
Happy Mammoth EstroControl
448829
Medicine
A
5/16/2024

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.